DSN Newswire

March 14, 2017

Report: 5 takeaways from the CBO’s analysis of AHCA

The Congressional Budget Office on Monday released its assessment of the American Health Care Act, the House GOP's proposal to replace Obamacare, and The Hill is outlining five of the biggest takeaways. Among them are the 24 million individuals who would be uninsured by 2026, with 14 million losing coverage next year, as well as the expected reduction in the federal deficit that the bill would bring about. The bill would also create extensive changes to Medicaid.  (The Hill)

May 25, 2017

Report: Walmart’s grocery share growth gains momentum

Walmart’s share of the $800 billion grocery market has grown to 21.5%, according to a report from CNBC that highlights Loop Capital analyst Andrew Wolf’s assessment of the retailer’s recent first-quarter results. Wolf notes that in Q1, Walmart outperformed U.S. supermarkets by 2.9%, which is up from the 1.6% outperformance it showed in Q4 2016. (CNBC)
May 24, 2017

Edgewell Personal Care reportedly launches Schick shave club

Edgewell Personal Care is taking the fight to its competitors with its latest initiative for its Schick shaving brand. Fox Business reported Wednesday that Edgewell had launched SchickHydro.com, offering a subscription service for refills of its blades that fit Schick razors. (Fox Business)  

May 23, 2017

CVS’ Merlo talks AHCA, opioid crisis on WBUR

CVS Health president and CEO Larry Merlo was the guest on Boston’s WBUR radio station’s “Here & Now” Tuesday, speaking with host Jeremy Hobson about such topics as tax reform, Amazon’s potential entry into pharmacy and the ongoing question of what changes will come to health care as the Senate considers the American Health Care Act. “I think there are elements that make sense from the Republican plan, but clearly there are other elements the Republican plan does not deal with,” Merlo said. “I think there are many open questions that have yet to be answered” (WBUR)
May 23, 2017

Report: Walgreens Boots Alliance communications chief to depart

Walgreens Boots Alliance’s SVP communications and international affairs Yves Romestan will be departing the company, according to a report in PRWeek. Laura Vergani, who will become VP international and divisional communications — moving up from her most recent role as VP international communications —will take on many of his responsibilities, the report said. (PRWeek)


May 17, 2017

NY Post: Colgate-Palmolive might be ready to sell

Colgate-Palmolive CEO Ian Cook would be open to a $100-per-share selling price for the company, according to a New York Post source. Cook reportedly floated the price at a recent investors meeting, which took place as such companies as Unilever, Johnson & Johnson, Warren Buffett’s 3G Capital and Procter & Gamble are floated as potential suitors for an acquisition. (New York Post)


May 5, 2017

Report: Illness-detection device wins $2.5 million

An XPRIZE competition has awarded $2.5 million to Penn.-based Frontier Medical Devices for its machine, DxtER, which uses sensors to check a person’s biological functions, vital signs and body chemistry, then uses an artificial intelligence engine come up with a diagnosis, according to a report from SingularityHub. The competition, inspired by a “Star Trek” device called the Tricorder, selected DxtER from entrants, all of whose devices had to weigh less than 5 lbs., diagnose 10 core health conditions and be smartphone- and tablet-compatible. (SingularityHub)


May 5, 2017

Report: L’Oreal Paris, Balmain’s Rousteing team on lipstick line

L’Oreal Paris is partnering with Balmain creative director Olivier Rousteing on a line of lipsticks that it will unveil before Paris Fashion Week in September, Women’s Wear Daily reported. The 31-year-old designer will oversee creative direction for the 12-lipstick line’s colors, as well as the design of packaging and its advertisement, with a plan to sell the product in places that carry L’Oreal Paris. Balmain stores and certain other retailers will carry jewel editions of the lipstick, the report said. (Women’s Wear Daily
May 1, 2017

Cramer: Walgreens wins no matter how Rite Aid merger plays

According to a report in TheStreet published Monday, CNBC "Mad Money" host Jim Cramer advised Walgreens shareholders to hold on to what they have, because no matter how the Rite Aid deal pans out, Walgreens will win. "If the deal's derailed by the FTC, I think we're going to get a truly monster buyback," Cramer said during an exclusive monthly conference call for members of his Action Alert Plus investment club. "If the deal is accepted, analysts can raise their numbers substantially. Those are good outcomes." (TheStreet)

April 27, 2017

Report: Hy-Vee to pilot format tailored to online shoppers

Hy-Vee is looking to unveil a new small-format store — tentatively called Hy-Vee Fast & Fresh — aimed at shoppers picking up groceries or making quick trips, according to a report in the Des Moines Register. The report notes that the store would be between 12,000 and 16,000 sq. ft. — smaller than the typical 90,000-sq.ft. store — and include fuel pumps and groceries, though much is still being worked out. (Des Moines Register)

April 25, 2017

NYT: Greg Wasson to chair new tech startup incubator

Former Walgreens CEO Greg Wasson's family investment office is joining forces with Innventure, a group that aims to develop businesses around new technologies lent by big corporations, The New York Times reported last week. P&G is expected to be the company's first partner. “Innventure will identify the opportunities, create a company, nurture it, then put in a management team to where it stands on its own — and then we move on,” Wasson, the company's chairman, told The New York Times. “What I think is most interesting is that we’re looking to help leverage their powerful R&D machine with our nimble entrepreneur team to identify the opportunities that they have developed.” In return, Innventure will have a stake in any companies it creates. (The New York Times)

April 18, 2017

NYT: Amid investigations, Lannett continues to raise prices

The New York Times is reporting that Philadephia-based generics company Lannett continues to raise prices on its drugs, even as the Justice Department is set to launch an anitrust investigations an Connecticut’s attorney general undertakes a drug price investigation into the company. Among the generics that have seen prices increase recently was anti-psychotic fluphenazine, which went from $43.50 to $870 for 100 10-mg capsules in 2016. (New York Times)


April 17, 2017

Report: Kroger pilots home delivery offering

RICHMOND, Va.— Kroger is test-marketing a home delivery component to its click-and-collect offering for customers in its Richmond, Va. area, the Richmond Times-Dispatch reported Monday. “Our customers don’t always have the time to shop in store but still want to bring quality items into their homes and onto their tables," Anne Jenkins, spokeswoman for Kroger Mid-Atlantic division, told the Times-Dispatch. "For us, home delivery is the solution and a natural progression for ClickList.” (Richmond Times-Dispatch)

April 14, 2017

Report: Texas mumps cases hit 22-year high

Texas has seen 221 people come down with the mumps this year — the highest number the state has had since 1994, when there were 234 cases, according to a report in Outbreak News Today. The Texas Dept. of State Health Services is advising healthcare providers to be on the look out for mumps in patients, as multiple outbreaks crop up around the state. (Outbreak News Today)

April 14, 2017

Thrifty White reportedly to open inside Grand Rapids, Minn., supermarket

Thrifty White Pharmacy will be opening its second pharmacy in Grand Rapids, Minn., according to a report from the Grand Rapids Herald-Review. The pharmacy will be taking over the pharmacy space inside a Milner’s Super One Foods store, offering Thrifty White’s medication synchronization, as well as a drive-through. (Herald-Review)
April 13, 2017

CNBC: Apple quietly developing next-generation diabetes solution

CNBC on Wednesday reported that Apple has hired a small team of engineers as part of a "secret" initiative to develop the next generation of diabetes management devices. "The initiative is far enough along that Apple has been conducting feasibility trials at clinical sites across the Bay Area and has hired consultants to help it figure out the regulatory pathways," CNBC reported, citing sources familiar with the effort. "Apple isn't the only technology company eyeing opportunities in the space, [however]. Verily, Google's life sciences team, is currently working on a 'smart' contact lens to measure blood sugar via the eye, and it partnered up with DexCom in 2015." (CNBC)